Mood stabilizer / anticonvulsant (chemically related to Tegretol)

Trileptal (oxcarbazepine) Withdrawal

Trileptal does not produce a classical withdrawal syndrome. The same considerations as other mood stabilizers / anticonvulsants apply: bipolar relapse risk and seizure recurrence risk warrant slow tapering. Generally has fewer drug interactions than Tegretol.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~2 hours for oxcarbazepine; ~9 hours for active metabolite.

Withdrawal timeline

Onset— Days to weeks

No acute withdrawal symptoms.

Peak risk window— Weeks 2-8

Mood or seizure recurrence emerges in this window.

Resolution— Variable

Re-stabilization depends on alternative treatment.

Common symptoms

  • Return of underlying condition
  • Sleep disturbance

Less common

  • Mild headache

Tapering guidance

  • A typical taper reduces by 300 mg every 1-2 weeks.
  • Plan alternative mood stabilization for bipolar patients before tapering.
  • Coordinate any taper with the prescribing physician.

Where ketamine therapy fits

Trileptal is compatible with at-home ketamine therapy. Continue Trileptal as prescribed during ketamine treatment unless the prescribing psychiatrist advises otherwise.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

Does Trileptal have a withdrawal syndrome?

Not in the SSRI sense. Risks are bipolar relapse and seizure recurrence.

Is Trileptal compatible with ketamine therapy?

Yes. Continue as prescribed unless your physician advises otherwise.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.